CLSA Statement on Proposed Budget Cuts to the NIH


For Immediate Release:
March 17, 2017

Bay Area & San Diego, Calif. – CLSA President & CEO Sara Radcliffe issued the following statement today regarding the President’s proposed $6 billion cut to the National Institutes of Health (NIH) in his budget blueprint. California Life Sciences Association (CLSA) is California’s largest and most influential life sciences advocacy and business leadership organization representing California’s leading life sciences innovators.

“On behalf of California’s life sciences innovators, a sector with over 3,000 firms employing nearly 300,000 people, California Life Sciences Association has deep concerns with the President’s proposed $6 billion cut to the NIH budget, which would have a chilling effect on lifesaving R&D to improve patient care. 

“The NIH has been chronically underfunded for years, and such a cut, compounded by mandatory sequestration in prior fiscal years, would put America at risk of ceding our global leadership in biomedical research and innovation. Now is not the time to reduce that investment, which is critical to the foundation and success of California’s biomedical R&D ecosystem.

“CLSA and our broad membership will continue to work with our California congressional delegation to guard against these harmful NIH cuts, that could put lifesaving cures and R&D at risk. The continued vibrancy of California’s life sciences industry relies heavily upon advances in science that are fueled by the NIH.”


To learn more about the NIH’s critical role in nurturing California’s life sciences industry, visit

About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged. Visit CLSA at, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.

Media Contact:
California Life Sciences Association (CLSA)
Will Zasadny | Director, Communications | 619-961-8848